Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-12-01T04:03:00.816Z Has data issue: false hasContentIssue false

Paediatrician’s guide to post-operative care for biventricular CHD: a review

Published online by Cambridge University Press:  27 September 2022

Lindsay Arthur
Affiliation:
Paediatric Cardiology Section, Department of Paediatrics, Arkansas Children’s Hospital, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Markus S. Renno
Affiliation:
Paediatric Cardiology Section, Department of Paediatrics, Arkansas Children’s Hospital, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Carolyn A. Altman
Affiliation:
Lille Frank Abercrombie Section of Cardiology, Department of Paediatrics, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX, USA
Sarosh P. Batlivala
Affiliation:
Interventional Cardiology Section, Heart Institute, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA
Julie Glickstein
Affiliation:
Paediatric Cardiology Section, Department of Paediatrics, Morgan Stanley Children’s Hospital of New York Presbyterian, Columbia University, New York, NY, USA
Jonathan N. Johnson
Affiliation:
Division of Paediatric Cardiology, Department of Paediatric and Adolescent Medicine, Mayo Clinic Children’s Center, Rochester, MN, USA
Jacob R. Miller
Affiliation:
Division of Paediatric Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis, St. Louis, MO, USA
Quang-Tuyen Nguyen
Affiliation:
Division of General Paediatrics, Department of Paediatrics, Primary Children’s Hospital, University of Utah, Salt Lake City, UT, USA
Elif Seda Selamet Tierney
Affiliation:
Division of Paediatric Cardiology, Department of Paediatrics, Lucile Packard Children’s Hospital, Stanford University, Palo Alto, CA, USA
Christina Ronai*
Affiliation:
Division of Paediatric Cardiology, Department of Paediatrics, Doernbecher Children’s Hospital, Oregon Health & Science University, Portland, OR, USA
*
Author for correspondence: Christina Ronai, MD, MSEd, 300 Longwood Avenue, Boston, MA 02115, USA. Tel: 617-355-6429; Fax: 617-739-6282. E-mail: christina.ronai@cardio.chboston.org
Rights & Permissions [Opens in a new window]

Abstract

Importance:

Paediatricians play an integral role in the lifelong care of children with CHD, many of whom will undergo cardiac surgery. There is a paucity of literature for the paediatrician regarding the post-operative care of such patients.

Observations:

The aim of this manuscript is to summarise essential principles and pertinent lesion-specific context for the care of patients who have undergone surgery or intervention resulting in a biventricular circulation.

Conclusions and relevance:

Familiarity with common issues following cardiac surgery or intervention, as well as key details regarding specific lesions and surgeries, will aid the paediatrician in providing optimal care for these patients.

Type
Review
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided that no alterations are made and the original article is properly cited. The written permission of Cambridge University Press must be obtained prior to any commercial use and/or adaptation of the article.
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Paediatricians care for patients with CHD, many of whom have undergone cardiac surgery. A wide range of issues may arise post-operatively, from wound care and sternal precautions to support for feeding and neurodevelopmental problems. While some of these are individually addressed in depth elsewhere, a concise and accessible summary for the paediatrician on common post-operative topics is underrepresented in the existing literature, particularly with regard for lesion-specific concerns and indications for surgery. Reference Johnson and Cetta1Reference Thompson, Burkhart, Johnson and Kamat3

The aim of this manuscript is to review essential principles for the optimal care of children who have undergone cardiac surgery or an interventional procedure. It builds on prior reports by providing additional pertinent lesion-specific context for patients who have undergone a biventricular operation. A separate manuscript in this edition of Cardiology in the Young similarly expands on the post-operative care of patients who have undergone a single ventricle palliation. Reference Ronai, Batlivala and Nguyen4

Universal issues following cardiac intervention or surgery

Paediatricians familiar with common issues among post-operative patients will be better positioned to help families navigate such medical, behavioural, and social concerns. The hospital discharge summary serves as a useful resource, especially for items such as dates of procedures, performed interventions, residual cardiac lesions, expected oxygen saturations, wound care, and return to activity. Though this is a valuable source for guidance, it may lack details on common topics elaborated upon below.

Wound care and sternal healing

Appropriate management of the post-operative surgical or cardiac catheterisation site is essential to prevent infection. If signs of a surgical site infection arise – such as redness, warmth, swelling, unexplained fever, or purulent discharge – the cardiologist and/or cardiothoracic surgeon will want to be notified immediately. To prevent this, post-operative patients should avoid direct spraying of water onto the incision during showers and submersion or soaking of the incision in a tub bath until the entire eschar and any surgical glue have naturally fallen off, leaving nothing but scar underneath. Post-catheterization patients should be similarly cautious with surgical sites, even though there is no large incision/eschar. Most interventional cardiologists recommend avoiding submersion and baths for a few days after the procedure, though showers and short baths are generally considered acceptable. Incisions should be dried well after bathing. Lotion, ointments, or powder on the incisions should generally be avoided. Once healed, sunscreen while exposed outdoors during the first year following surgery may decrease the prominence of scarring. Reference Due, Rossen, Sorensen, Kliem, Karlsmark and Haedersdal5,Reference Monstrey, Middelkoop and Vranckx6

There are many types of sutures used to close post-operative incisions, and many or all may be removed prior to hospital discharge. A few extruding sutures may be left in place for certain patients and may need to be removed at a follow-up appointment. The cardiologist or surgical team often removes them, but in some cases, removal by the paediatrician may be necessary to save the family a long return trip for subspecialty services. Adolescent females should consider use of support bras to prevent tension on the incision. Occasionally, wound vacs may be used to minimise tension on the incision and promote healing; should wound vac concerns arise, they should be discussed with the cardiologist and/or cardiothoracic surgeon.

To prevent separation of the healing sternum, “sternal pre-cautions” are recommended for the first 6–8 weeks after sternotomy. The specific precautions can vary based on age and expected activities. Reference Clifton, Cruz, Patel, Cahalin and Moore7Reference Katijjahbe, Granger and Denehy9 Often, they include activity limitations such as avoiding gym class, contact sports, weightlifting, and carrying heavy backpacks and bags. Infants should be scooped up in a cradle position rather than lifted from under the arms, as this places significant stress on the sternum. Infants may have tummy time while awake, if tolerated and not in apparent pain.

Return to activity

Specific activity restrictions beyond those required for sternal precautions are determined on an individual basis and are typically outlined in the discharge summary or early post-operative cardiology follow-up note. Patients may feel tired for a couple of weeks after an operation and need to rest during the day. In general, patients can resume typical daily activities – such as walking, light chores – after hospital discharge. They can typically return to school within 1–3 weeks of discharge and should be able to return to their usual exercise activities within a few weeks. Adolescents and older children who change classrooms throughout the day may benefit from additional time allowance between classes for a few weeks.

Catheterisation patients should avoid activities that involve significant leg strain and motion, such as bicycle riding and weightlifting, for at least 5 days after the procedure and potentially longer if large catheters were used.

Common medications

Common medications prescribed in the post-operative period include diuretics such as furosemide, chlorothiazide, and spironolactone. These medications have the potential to cause electrolyte imbalances, necessitating caution if a gastrointestinal illness arises. Usually, these diuretics are weaned during the early post-operative period.

Patients who were exposed to prolonged sedative and analgesics (e.g., opioids and benzodiazepines) may require slow weans after hospital discharge. Often, a wean plan is formulated in collaboration with a hospital pharmacist. In some cases, a wean that is too aggressive may result in withdrawal symptoms such as irritability, yawning, sweating, gagging, and vomiting.

Some cardiac surgeries and interventions require anticoagulation to preserve the integrity of the repair and/or device. Commonly used medications include warfarin, enoxaparin, and aspirin, among others. The primary paediatric cardiologist will define the target therapeutic levels (e.g. international normalized ratio (INR), anti-Xa), in collaboration with the cardiac surgeon or interventional cardiologist. Reference Jain and Vaidyanathan10 The cardiologist is often responsible for monitoring drug levels, though some centres utilise a haematology team-based monitoring program. Occasionally, the paediatrician may aid in drug monitoring as well.

Neonatal feeding

Optimal growth is a crucial issue for babies after cardiac surgery, with many neonates experiencing feeding difficulties in the post-operative period. Reference Canada, Mullins, Pearo and Spoede11 Caloric fortification of feeds may be required to achieve adequate weight gain. Occasionally, poor oral motor skills necessitate nasogastric feeds or placement of a gastrostomy tube. Ancillary services such as speech therapy and occupational therapy may be utilised to minimise the risk of oral aversion and maintain oral motor feeding skills. The paediatrician is an important partner for the paediatric cardiologist in optimising and monitoring weight gain in the post-operative period.

Immunisations

Immunisations have historically been deferred around the time cardiac surgery. One recent study demonstrated that cardiopulmonary bypass does not significantly lower existing titres of vaccine-related antibodies, and thus there may be no need to defer immunizations prior to surgery. Reference Vergales, Dean and Raphael12 However, fevers shortly before surgery or in the early post-operative period may cloud management, and as such, some degree of deferment may be appropriate. The primary paediatric cardiologist should specify if one or more vaccines need to be deferred from the routine immunisation schedule or if the patient qualifies for additional immunizations. For example, some post-operative and post-catheterization patients may still be deemed to have “hemodynamically significant congenital heart disease,” so palivizumab (Synagis) may continue to be indicated. 13

Neurodevelopmental outcomes

Infants and children who have undergone cardiac surgery are at risk for developmental delay and specific learning disabilities later in childhood. Reference Marino, Lipkin and Newburger14 The causes are multi-factorial including abnormal foetal circulation with potentially altered neurological development in utero, undergoing procedures that require the use of inhaled anaesthetics and cardiopulmonary bypass, periods of desaturation (either acute or chronic), and underlying genetic syndromes. Common developmental issues include language delay, learning difficulties, and attentional challenges. Adherence to the developmental screenings recommended by Bright Futures guidelines is essential to identify and treat such delays early in childhood. Reference Hagan, Shaw and Duncan15 Early intervention support should be initiated when indicated. Likewise, schools are well positioned to identify and provide support services for learning disabilities. The Cardiac Neurodevelopmental Outcome Collaborative has published recommendations for the care of these patients. Reference Ware, Butcher and Latal16

Dental care and SBE prophylaxis

Infective endocarditis can be a life-threatening complication, especially after a cardiac intervention. As such, routine dental hygiene is essential to preventing caries and dental abscesses that can lead to bacteraemia and endocarditis. The paediatrician can help reiterate the importance of regular dental evaluations for patients with CHD. In addition, antibiotic prophylaxis to prevent spontaneous bacterial endocarditis may be indicated according to current guidelines. Reference Wilson, Taubert and Gewitz17,Reference Wilson, Gewitz and Lockhart18 Given rapidly evolving therapies, an individual patient’s characteristics may not fall within guideline descriptors, so the paediatric cardiologist may specify if prophylaxis is indicated.

Lesion specific considerations

Paediatricians familiar with common congenital heart lesions will be better equipped to care for their patients in the months following intervention and surgery.

Atrial septal defects

Atrial septal defects that persist past toddlerhood are typically closed between three and five years of age to prevent damage to the pulmonary vascular bed and allow the right heart to remodel to normal size. Options for repair include device closure in the cardiac catheterisation laboratory and surgical closure with a patch or directly with sutures in the operating room. The decision for which approach is preferred depends on the size and location of the atrial septal defect.

Because of its minimally invasive nature and short recovery, transcatheter atrial septal defect device closure is typically preferred if there are adequate rims around the defect to keep the device in place. Potential complications following device closure include device migration in the short term and device erosion into the atrial wall or aorta in the longer term. Fortunately, these complications are quite rare, with the former occurring in roughly 0.55% and the latter in roughly 0.1% of cases. Reference Moore, Hegde and El-Said19

Surgical repair of atrial septal defects remains very safe with a mortality rate of approximately 0.1%. 20 However, up to 40% of patients may develop post-pericardiotomy syndrome, which is characterised by pericardial inflammation and effusion in the first few weeks after surgery. Reference Heching, Bacha and Liberman21,Reference Imazio, Brucato, Ferrazzi, Spodick and Adler22 Symptoms and signs of concern include fever, chest pain, abdominal pain, emesis, fatigue, and pericardial friction rub on exam. Evaluation typically includes an echocardiogram but may also include an electrocardiogram and chest X-ray. To prevent post-pericardiotomy syndrome, some centres place patients on non-steroidal anti-inflammatory therapies for 6–8 weeks following repair, though some data have challenged the efficacy of this approach. Reference Rabinowitz, Meyer, Kholwadwala, Kohn and Bakar23

Patent ductus arteriosus

When the patent ductus arteriosus does not close spontaneously, there are specific circumstances in which closure is indicated. The first is in the pre-mature neonate whose left to right shunt is haemodynamically significant. In these cases, the first-line treatment is often medical management with either non-steroidal anti-inflammatory drugs or acetaminophen. If medical therapy fails, then an intervention is often indicated, either surgical ligation or transcatheter closure. The second scenario is in the infant/toddler who does well clinically, but whose patent ductus arteriosus persists with resultant left-heart dilation from the volume load. In these cases, closure is warranted since the patent ductus arteriosus is haemodynamically significant. The third scenario is toddlers, children, and adults in whom the patent ductus arteriosus is small but remains audible on exam. Though based largely on expert opinion, closure is typically recommended because the lifetime risk of endocarditis is thought to be greater than the one-time risk of closure.

Options for patent ductus arteriosus occlusion include transcatheter patent ductus arteriosus device placement and surgical ligation via thoracotomy or video-assisted thoracoscopic surgery. Because of its minimally invasive nature, the former is typically preferred, though both approaches carry a low procedural risk. Given the recent advent of devices for pre-mature infants, the indications and approaches are evolving and trending toward transcatheter closure. Reference Sathanandam, Balduf and Chilakala24,Reference Sathanandam, Gutfinger and O'Brien25 Potential complications following transcatheter patent ductus arteriosus device closure include device migration, with or without encroachment into the aorta and/or pulmonary artery, which rarely requires re-intervention and occasionally needs to be followed over time by a paediatric cardiologist.

Ventricular septal defects

There are generally two instances where surgical closure of a ventricular septal defect is warranted. The first is in patients whose defects are large, unlikely to close spontaneously, and result in symptoms and/or chamber dilatation. In these cases, the congestive heart failure symptoms are typically managed medically until surgical closure between three and six months of age. The second common indication for ventricular septal defect closure is for defects of any size adjacent to the aortic valve, resulting in valvular distortion, prolapse, and/or aortic insufficiency.

Ventricular septal defect surgery typically involves sewing a patch of fabric or pericardium over the defect, though occasionally the ventricular septal defect can be closed directly with sutures. The operation carries a low mortality rate of approximately 0.2%. 20 Up to 8% of patients may develop complete heart block during the operation, though most resolve spontaneously within a few days. Reference Siehr, Hanley, Reddy, Miyake and Dubin26 A right bundle branch block is commonly seen on electrocardiogram after ventricular septal defect closure; this is typically of little haemodynamic significance but may result in a widely split S2 on examination. Post-operative follow-up includes monitoring for any residual defects and/or aortic insufficiency.

Atrioventricular septal (canal) defects

An atrioventricular septal defect is an endocardial cushion defect in the crux (centre) of the heart, resulting in an abnormal atrioventricular valve and septal defects at the atrial and/or ventricular levels. Endocardial cushion defects are commonly associated with trisomy 21. A “complete” atrioventricular septal defect includes both an atrial septal defect and a ventricular septal defect. Cases in which the ventricular septal defect is partially closed by membranous tissue may be referred to as a “transitional” atrioventricular septal defect. An “incomplete” or “partial” atrioventricular septal defect occurs when the ventricular septal defect is completely closed by fibrous tissue, though the left atrioventricular valve remains abnormal.

Surgical repair of complete atrioventricular septal defects is typically undertaken around three to six months of age, while transitional and partial atrioventricular septal defects can often be repaired at older ages, typically around three to five years of age. The repair involves closing the atrial and ventricular septal defects and dividing the common atrioventricular valve into functional left and right atrioventricular valves. Like isolated ventricular septal defect closures, there is a risk of acquired heart block with operation. The most common post-operative complications include left and right atrioventricular valve stenosis and/or regurgitation, development of left ventricular outflow tract obstruction, and residual atrial septal defects and ventricular septal defects, necessitating reintervention in up to 20% of patients. Reference Fong, Betts and Bell27,Reference Mery and Zea-Vera28

Tetralogy of Fallot

Neonates with tetralogy of Fallot and severe cyanosis may require surgical or catheter-based intervention prior to hospital discharge to ensure adequate pulmonary blood flow. However, the “complete repair” of tetralogy of Fallot is generally undertaken around three to six months of age and consists of ventricular septal defect closure and relief of any obstruction of flow from the right ventricle to the distal pulmonary arteries. A pulmonary valve-sparing repair is preferred, but in cases where the pulmonary valve is too hypoplastic, a transannular patch may be required, sacrificing the pulmonary valve’s competency. Reference Blais, Marelli and Vanasse29 While pulmonary insufficiency following transannular patch repair is universal, it can also develop in patients who have undergone valve-sparing repair.

Over time, this insufficiency leads to progressive right ventricular dilatation, eventually necessitating pulmonary valve replacement. Reference Alvarez-Fuente, Garrido-Lestache and Fernandez-Pineda30 The timing of pulmonary valve replacement varies considerably based on numerous factors, including size and function of the right ventricle, presence of symptoms, and arrhythmias. Some children may also develop recurrent pulmonary artery stenoses necessitating intervention, including dilation and/or stent placement via cardiac catheterisation or arterioplasty at the time of a subsequent operation. Cardiac MRI serves as an important complementary diagnostic modality to echocardiography and catheterization in patients with history of tetralogy of Fallot repair. Reference Sachdeva, Valente and Armstrong31

D-looped transposition of the great arteries

Neonates born with transposition of the great arteries require surgical repair within the first few weeks of life to survive. Typically, this is accomplished with an arterial switch operation, in which the great arteries are reversed to re-establish normal arterial connections to the ventricles. This involves transferring the coronary arteries as well. In addition, a LeCompte manoeuvre is often required, draping the branch pulmonary arteries over the front of the ascending aorta, rather than having the right pulmonary artery pass under the aortic arch.

Common residual lesions include aortic or pulmonary stenoses and/or insufficiency, as well as neo-aortic root dilatation. Reference Fraser, Chacon-Portillo and Well32,Reference Co-Vu, Ginde, Bartz, Frommelt, Tweddell and Earing33 Recurrent branch pulmonary artery stenoses, more likely when a LeCompte procedure is performed, may require one or more subsequent percutaneous interventions. Reference Lee, Abdullah Shahbah, El-Said, Rios, Ratnayaka and Moore34 Coronary insufficiency, though rare, may develop over time and warrant follow-up by the primary paediatric cardiologist. Reference Cohen, Eidem and Cetta35,Reference El-Segaier, Lundin, Hochbergs, Jogi and Pesonen36

Total anomalous pulmonary venous connection

Most new-borns with total anomalous pulmonary venous connection undergo surgical intervention prior to hospital discharge, though exceptions exist. Important post-operative complications include pulmonary vein stenoses, which can present as tachypnoea or worsening shortness of breath and warrant urgent evaluation by the cardiologist. Reference Devaney, Ohye and Bove37

Truncus arteriosus

Surgical repair of truncus arteriosus is generally performed early in infancy due to high output heart failure from torrential pulmonary blood flow and to minimise resultant damage to the pulmonary vascular bed. The Rastelli repair consists of closing the ventricular septal defect, removing the pulmonary arteries from the aorta, and placing a valved conduit from the right ventricle to the pulmonary arteries. Truncal valve stenosis and insufficiency may complicate the repair and prognosis. Furthermore, about one-third of babies born with truncus arteriosus have 22q11.2 deletion syndrome (DiGeorge Syndrome), which can result in important hypocalcaemia and immunodeficiency. Pulmonary conduit stenosis and/or insufficiency ultimately necessitates pulmonary valve replacement. Additional complications include branch pulmonary artery stenoses and truncal root dilatation. Reference Russell, Pasquali and Jacobs38

Coarctation of the aorta and interrupted aortic arch

Aortic arch obstruction is typically identified and surgically repaired in the neonatal period, though diagnoses in later childhood do still occur. Recurrent laryngeal nerve injury after manipulation of the aortic arch can result in vocal cord paralysis, which may complicate post-operative feeding. In the months to years following repair, recurrent coarctation may develop and necessitate balloon angioplasty and/or stent placement. Some repair techniques utilise the subclavian artery, so cognizance of subclavian artery origins and patency guides interpretation of non-invasive upper and lower extremity blood pressures and pulses. A gradient of greater than 20 mmHg (upper extremity higher than lower extremity) is considered haemodynamically significant and may warrant intervention.

Systemic hypertension is common in patients following aortic arch repairs and should be treated if detected. Reference Rajbanshi, Joshi and Pradhan39,Reference Canniffe, Ou, Walsh, Bonnet and Celermajer40 Hypertension that is resistant to multiple medications may be due to recurrent coarctation as well. Reference Brown, Burkhart and Connolly41 Additional important complications include aortic and cerebral aneurysms. Because significant morbidity and mortality arise from cardiovascular causes in patients who have undergone coarctation repair, it is imperative that comorbid hypertension is adequately treated. Reference Hoimyr, Christensen and Emmertsen42

Aortic stenosis

Abnormalities of aortic valve development (e.g., bicuspid aortic valve) can result in aortic stenosis. When severe and not appropriate for balloon valvuloplasty, one of several surgical options is chosen based on the patient’s size, potential for growth, and tolerance for chronic anticoagulation. The Ross operation utilises the patient’s native pulmonary valve to replace the dysfunctional aortic valve, and a pulmonary homograft or valved conduit is placed in the pulmonary position. This has the advantage of a neo-aortic valve that grows with the patient but typically necessitates one or more future pulmonary valve replacements for stenosis and/or insufficiency. Alternatively, the aortic valve can be replaced with either a bioprosthetic or mechanical valve. Bioprosthetic valves do not typically require chronic anticoagulation, though they have a limited lifespan. Mechanical valves have the potential to last a lifetime but require chronic anticoagulation, carrying roughly a 1–3% risk of thrombosis or bleeding per valve-year. Reference Schlein, Simon, Wollenek, Base, Laufer and Zimpfer43,Reference Myers, Mokashi and Horgan44 Neither of these valves have potential to grow with the child. Paediatricians can serve as important allies in encouraging adherence to anticoagulation, oral hygiene, and endocarditis prophylaxis recommendations, as non-adherence can rapidly lead to complications including aortic stenosis, aortic insufficiency, and endocarditis.

Pulmonary stenosis

Pulmonary valve stenosis can be relieved by balloon angioplasty or surgical valvotomy. Potential complications include residual pulmonary stenosis or insufficiency. In some cases, these can ultimately necessitate pulmonary valve replacement.

Ebstein anomaly

In Ebstein anomaly, the tricuspid valve is displaced apically into the right ventricle and can have varying degrees of dysplasia and regurgitation. In milder cases requiring surgery, tricuspid valve repair or tricuspid valve replacement may be performed, resulting in a biventricular repair. However, in more severe cases, the functional right ventricle may be too small to handle all the systemic venous return, necessitating at least partial progression down the single ventricle pathway. Complications of biventricular repair include residual tricuspid stenosis and/or regurgitation, as well as supraventricular tachycardia.

Vascular ring

Several embryologic substrates result in a vascular ring encircling the trachea and oesophagus. When this substrate results in respiratory insufficiency, frequent respiratory infections, or swallowing difficulties, vascular ring division is indicated. This is typically undertaken via lateral thoracotomy or video-assisted thoracoscopic surgery. Reference Lee, Yang and Jun45 Residual tracheal hypoplasia and/or malacia typically improves with patient growth after vascular ring division. Swallowing difficulties also typically resolve, though in some cases, the presence of a retroesophageal vascular structure continues to cause symptoms.

Congenitally corrected transposition of the great arteries

Children with congenitally corrected transposition of the great arteries have both atrioventricular discordance and ventriculoarterial discordance. This results in deoxygenated blood appropriately being pumped to the pulmonary arteries and oxygenated blood appropriately being pumped to the aorta. Children who have associated lesions such as ventricular septal defects or pulmonary stenosis may require surgery early in life. Complete heart block commonly complicates post-operative recovery, in some cases necessitating placement of a pacemaker.

Children without associated lesions may not require surgery for many years. However, the morphologic right ventricle (typically the anatomically left-sided ventricle) is not designed to pump against systemic vascular resistance for a lifetime, ultimately leading to pre-mature heart failure in early to mid-adulthood if unaddressed. Some centres pre-empt this by performing a “double switch” operation, in which an atrial switch is performed simultaneously with an arterial switch. In addition to the above complications associated with arterial switch, the atrial switch introduces additional risks of atrial arrhythmias and atrial baffle stenoses and/or leaks. Baffle stenoses and leaks can often be addressed in the catheterisation laboratory.

Special Circumstances

Pulmonary valve replacement

As described above, many forms of repaired and unrepaired CHD require one or more pulmonary valve replacements as children grow. Surgical pulmonary valve replacement carries a low procedural risk. Hospital stay for surgical pulmonary valve replacement is typically around 2–5 days, with a post-operative mortality less than 1%. 20 Most surgically placed pulmonary valves last between 4 and 15 years before requiring replacement, either due to valve dysfunction or patient growth. Reference Baird, Chavez and Sleeper46

Transcatheter pulmonary valve replacement utilises a percutaneous approach and requires a shorter hospital stay, typically under 24 hours. Though data are relative sparse and still evolving, there has been question as to whether some transcatheter valves have a higher risk of bacterial endocarditis, approaching 2.5% per patient-year. Reference McElhinney, Sondergaard and Armstrong47,Reference McElhinney48 As mentioned earlier, proper dental hygiene is critically important for these patients. Similarly, aspirin has been shown to decrease this risk, so adherence is of particular importance. The paediatrician should be aware that an unexplained fever lasting greater than 5 days should prompt consideration of obtaining a blood culture.

Balloon and stent arterioplasty and venoplasty

Numerous congenital heart lesions, whether unrepaired or due to a complication of repair, benefit from percutaneous angioplasty and/or stent placement. Reperfusion injury to the affected lung can occur following intervention for branch pulmonary artery stenoses; this typically occurs the night of the procedure and is treated with diuretics and oxygen. Re-stenosis is common following intervention for acquired pulmonary vein stenoses, often necessitating multiple repeat interventions. Balloon dilation of recurrent aortic coarctation carries a risk of aortic aneurysm, dissection, embolisation, and stroke. Percutaneous right ventricle to pulmonary artery conduit interventions may result in worsening pulmonary insufficiency. In general, stents require endocarditis prophylaxis for 6 months following placement, with aspirin therapy at the discretion of the cardiologist.

Pacemaker and defibrillator placement

Patients with documented sinus node dysfunction, atrioventricular block, and life-threatening arrhythmias may have a pacemaker or implanted cardioverter-defibrillator placed. Such devices can be placed either via a transvenous or epicardial approach, depending on patient size and anatomy. Complications following placement include surgical site infection and endocarditis. Battery life in a pacemaker or defibrillator is limited and generally necessitates replacement of the device. The wires typically last much longer and only need to be replaced when no longer conducting effectively; these are routinely tested during device interrogation.

MRI in patients with implanted electronic devices was previously regarded as an absolute contraindication. Recent studies demonstrating safety have resulted in guideline revisions that allow some patients with devices to undergo MRI. Reference Lupo, Cappato and Di Leo49,Reference Bireley, Kovach and Morton50 Such studies are typically performed under the guidance of a supervising radiologist or cardiologist in collaboration with the device manufacturer.

Conclusion

Paediatricians are integral in the lifelong care of children with CHD. Familiarity with common issues following cardiac surgery or intervention, as well as key details regarding specific lesions and surgeries, will aid the paediatrician in caring for these patients well.

Acknowledgement

None.

Financial support

This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.

Conflicts of interest

None.

Footnotes

a

Lindsay Arthur and Markus S. Renno contributed equally as co-first authors.

References

Johnson, JN, Cetta, F. Essentials in the Post-operative evaluation of congenital heart disease. US Cardiology Review 2009; 6: 107114. DOI 10.15420/usc.2009.6.2.107.CrossRefGoogle Scholar
Tweddell, JS, Hoffman, GM. Postoperative management in patients with complex congenital heart disease. semin thorac cardiovasc surg pediatr card surg annu. Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual 2002; 5: 187205. DOI 10.1053/pcsu.2002.31499.CrossRefGoogle Scholar
Thompson, JL, Burkhart, HM. Office Care of the Child After Heart Surgery. In: Johnson, JN, Kamat, DM (eds). Common Cardiac Issues in Pediatrics. American Academy of Pediatrics, 2018: 237244.CrossRefGoogle Scholar
Ronai, C, Batlivala, SP, Nguyen, Q-T, et al. Paediatrician’s guide to postoperative care for biventricular congenital heart disease: A Review. Cardiol Young 2022. DOI 10.1017/S1047951122002955.Google Scholar
Due, E, Rossen, K, Sorensen, LT, Kliem, A, Karlsmark, T, Haedersdal, M. Effect of UV irradiation on cutaneous cicatrices: a randomized, controlled trial with clinical, skin reflectance, histological, immunohistochemical and biochemical evaluations. Acta Derm Venereol 2007; 87: 2732. DOI 10.2340/00015555-0154.CrossRefGoogle ScholarPubMed
Monstrey, S, Middelkoop, E, Vranckx, JJ, et al. Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg 2014; 67: 10171025. DOI 10.1016/j.bjps.2014.04.011.CrossRefGoogle ScholarPubMed
Clifton, A, Cruz, G, Patel, Y, Cahalin, LP, Moore, JG. Sternal precautions and prone positioning of infants following median sternotomy: a nationwide survey. Pediatr Phys Ther 2020; 32: 339345. DOI 10.1097/PEP.0000000000000734.CrossRefGoogle ScholarPubMed
El-Ansary, D, LaPier, TK, Adams, J, et al. An Evidence-Based perspective on movement and activity following median sternotomy. Phys Ther 2019; 99: 15871601. DOI 10.1093/ptj/pzz126.CrossRefGoogle ScholarPubMed
Katijjahbe, MA, Granger, CL, Denehy, L, et al. Standard restrictive sternal precautions and modified sternal precautions had similar effects in people after cardiac surgery via median sternotomy (’SMART' trial): a randomised trial. J Physiother 2018; 64: 97106. DOI 10.1016/j.jphys.2018.02.013.CrossRefGoogle Scholar
Jain, S, Vaidyanathan, B. Oral anticoagulants in pediatric cardiac practice: a systematic review of the literature. Ann Pediatr Cardiol 2010; 3: 3134. DOI 10.4103/0974-2069.64371.Google Scholar
Canada, NL, Mullins, L, Pearo, B, Spoede, E. Optimizing perioperative nutrition in pediatric populations. Nutr Clin Pract 2016; 31: 4958. DOI 10.1177/0884533615622639.CrossRefGoogle ScholarPubMed
Vergales, J, Dean, P, Raphael, J, et al. Cardiopulmonary bypass and infant vaccination titers. Pediatrics 2020; 145: 912. DOI 10.1542/peds.2019-1716.CrossRefGoogle ScholarPubMed
American Academy of Pediatrics Committee on Infectious D, American Academy of Pediatrics Bronchiolitis Guidelines C. American academy of pediatrics committee on infectious D, american academy of pediatrics bronchiolitis guidelines C. updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2014; 134: 415420. DOI 10.1542/peds.2014-1665.CrossRefGoogle Scholar
Marino, BS, Lipkin, PH, Newburger, JW, et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the american heart association. Circulation 2012; 126: 11431172. DOI 10.1161/CIR.0b013e318265ee8a.CrossRefGoogle ScholarPubMed
Hagan, JF, Shaw, JS, Duncan, PM. Bright futures : guidelines for health supervision of infants, children, and adolescents, vol. xix, 4th edn. Bright Futures/American Academy of Pediatrics, 2017, 868.CrossRefGoogle Scholar
Ware, J, Butcher, JL, Latal, B, et al. Neurodevelopmental evaluation strategies for children with congenital heart disease aged birth through 5 years: recommendations from the cardiac neurodevelopmental outcome collaborative. Cardiol Young 2020; 30: 16091622. DOI 10.1017/S1047951120003534.CrossRefGoogle ScholarPubMed
Wilson, W, Taubert, KA, Gewitz, M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young. In and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116: 17361754. DOI 10.1161/CIRCULATIONAHA.106.183095.CrossRefGoogle Scholar
Wilson, WR, Gewitz, M, Lockhart, PB, et al. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the american heart association. Circulation 2021; 143: e963e978. DOI 10.1161/CIR.0000000000000969.CrossRefGoogle ScholarPubMed
Moore, J, Hegde, S, El-Said, H, et al. Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv 2013; 6: 433442. DOI 10.1016/j.jcin.2013.02.005.CrossRefGoogle ScholarPubMed
Society of Thoracic S. Congenital Heart Surgery Database. Executive Summary. All Patients - Spring 2019 Harvest.Google Scholar
Heching, HJ, Bacha, EA, Liberman, L. Post-pericardiotomy syndrome in pediatric patients following surgical closure of secundum atrial septal defects: incidence and risk factors. Pediatr Cardiol 2015; 36: 498502. DOI 10.1007/s00246-014-1039-7.CrossRefGoogle ScholarPubMed
Imazio, M, Brucato, A, Ferrazzi, P, Spodick, DH, Adler, Y. Postpericardiotomy syndrome: a proposal for diagnostic criteria. J Cardiovasc Med (Hagerstown) 2013; 14: 351353. DOI 10.2459/JCM.0b013e328353807d.CrossRefGoogle ScholarPubMed
Rabinowitz, EJ, Meyer, DB, Kholwadwala, P, Kohn, N, Bakar, A. Does prophylactic ibuprofen after surgical atrial septal defect repair decrease the rate of Post-Pericardiotomy syndrome? Pediatr Cardiol 2018; 39: 15351539. DOI 10.1007/s00246-018-1926-4.CrossRefGoogle ScholarPubMed
Sathanandam, S, Balduf, K, Chilakala, S, et al. Role of transcatheter patent ductus arteriosus closure in extremely low birth weight infants. Catheter Cardiovasc Interv 2019; 93: 8996. DOI 10.1002/ccd.27808.CrossRefGoogle ScholarPubMed
Sathanandam, SK, Gutfinger, D, O'Brien, L, et al. Amplatzer piccolo occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients >/=700 grams. Catheter Cardiovasc Interv 2020; 96: 12661276. DOI 10.1002/ccd.28973.CrossRefGoogle ScholarPubMed
Siehr, SL, Hanley, FL, Reddy, VM, Miyake, CY, Dubin, AM. Incidence and risk factors of complete atrioventricular block after operative ventricular septal defect repair. Congenit Heart Dis 2014; 9: 211215. DOI 10.1111/chd.12110.CrossRefGoogle ScholarPubMed
Fong, LS, Betts, K, Bell, D, et al. Complete atrioventricular septal defect repair in Australia: results over 25 years. J Thorac Cardiovasc Surg 2020; 159: 10141025 e8. DOI 10.1016/j.jtcvs.2019.08.005.CrossRefGoogle ScholarPubMed
Mery, CM, Zea-Vera, R, Chacon-Portillo. MA, etal, contemporary outcomes after repair of isolated and complex complete atrioventricular septal defect. Ann Thorac Surg 2018; 106: 14291437. DOI 10.1016/j.athoracsur.2018.06.006.CrossRefGoogle Scholar
Blais, S, Marelli, A, Vanasse, A, et al. Comparison of Long-term outcomes of valve-Sparing and transannular patch procedures for correction of tetralogy of fallot. JAMA Netw Open 2021; 4: e2118141. DOI 10.1001/jamanetworkopen.2021.18141.CrossRefGoogle ScholarPubMed
Alvarez-Fuente, M, Garrido-Lestache, E, Fernandez-Pineda, L, et al. Timing of Pulmonary Valve Replacement: How Much Can the Right Ventricle Dilate Before it Looses Its Remodeling Potential? Pediatric Cardiology 2016; 37: 601605. DOI 10.1007/s00246-015-1320-4.CrossRefGoogle ScholarPubMed
Sachdeva, R, Valente, AM, Armstrong, AK, et al. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease: A Report of the American College of Cardiology Solution Set Oversight Committee and Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Coll Cardiol 2020; 75: 657703. DOI 10.1016/j.jacc.2019.10.002.CrossRefGoogle Scholar
Fraser, CD Jr., Chacon-Portillo, MA, Well, A, et al. Twenty-Three-Year experience with the arterial switch operation: expectations and Long-Term outcomes. Semin Thorac Cardiovasc Surg 2020, 32,. DOI 10.1053/j.semtcvs.2020.01.004.CrossRefGoogle Scholar
Co-Vu, JG, Ginde, S, Bartz, PJ, Frommelt, PC, Tweddell, JS, Earing, MG. Long-term outcomes of the neoaorta after arterial switch operation for transposition of the great arteries. Ann Thorac Surg 2013; 95: 16541659. DOI 10.1016/j.athoracsur.2012.10.081.CrossRefGoogle ScholarPubMed
Lee, J, Abdullah Shahbah, D, El-Said, H, Rios, R, Ratnayaka, K, Moore, J. Pulmonary artery interventions after the arterial switch operation: unique and significant risks. Congenit Heart Dis 2019; 14: 288296. DOI 10.1111/chd.12726.CrossRefGoogle ScholarPubMed
Cohen, MS, Eidem, BW, Cetta, F, et al. Multimodality imaging guidelines of patients with transposition of the great arteries: a report from the american society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance and the society of cardiovascular computed tomography. J Am Soc Echocardiogr 2016; 29: 571621. DOI 10.1016/j.echo.2016.04.002.CrossRefGoogle Scholar
El-Segaier, M, Lundin, A, Hochbergs, P, Jogi, P, Pesonen, E. Late coronary complications after arterial switch operation and their treatment.. Catheter Cardiovasc Interv 2010; 76: 10271032. DOI 10.1002/ccd.22605.CrossRefGoogle ScholarPubMed
Devaney, EJ, Ohye, RG, Bove, EL. Pulmonary vein stenosis following repair of total anomalous pulmonary venous connection. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006; 9: 5155. DOI 10.1053/j.pcsu.2006.02.023.CrossRefGoogle Scholar
Russell, HM, Pasquali, SK, Jacobs, JP, et al. Outcomes of repair of common arterial trunk with truncal valve surgery: a review of the society of thoracic surgeons congenital heart surgery database. Ann Thorac Surg Jan 2012; 93: 1649. discussion 169. DOI 10.1016/j.athoracsur.2011.04.121.CrossRefGoogle Scholar
Rajbanshi, BG, Joshi, D, Pradhan, S, et al. Primary surgical repair of coarctation of the aorta in adolescents and adults: intermediate results and consequences of hypertension. Eur J Cardiothorac Surg 2019; 55: 323330. DOI 10.1093/ejcts/ezy228.CrossRefGoogle ScholarPubMed
Canniffe, C, Ou, P, Walsh, K, Bonnet, D, Celermajer, D. Hypertension after repair of aortic coarctation--a systematic review. Int J Cardiol 2013; 167: 24562461. DOI 10.1016/j.ijcard.2012.09.084.CrossRefGoogle ScholarPubMed
Brown, ML, Burkhart, HM, Connolly, HM, et al. Coarctation of the aorta: lifelong surveillance is mandatory following surgical repair. J Am Coll Cardiol 2013; 62: 10201025. DOI 10.1016/j.jacc.2013.06.016.CrossRefGoogle ScholarPubMed
Hoimyr, H, Christensen, TD, Emmertsen, K, et al. Surgical repair of coarctation of the aorta: up to 40 years of follow-up. Eur J Cardiothorac Surg 2006; 30: 910916. DOI 10.1016/j.ejcts.2006.09.016.CrossRefGoogle ScholarPubMed
Schlein, J, Simon, P, Wollenek, G, Base, E, Laufer, G, Zimpfer, D. Aortic valve replacement in pediatric patients: 30 years single center experience. J Cardiothorac Surg 2021; 16: 259. DOI 10.1186/s13019-021-01636-2.CrossRefGoogle ScholarPubMed
Myers, PO, Mokashi, SA, Horgan, E, et al. Outcomes after mechanical aortic valve replacement in children and young adults with congenital heart disease. J Thorac Cardiovasc Surg Jan 2019; 157: 329340. DOI 10.1016/j.jtcvs.2018.08.077.CrossRefGoogle Scholar
Lee, JH, Yang, JH, Jun, TG. Video-assisted thoracoscopic division of vascular rings. Korean J Thorac Cardiovasc Surg 2015; 48: 7881. DOI 10.5090/kjtcs.2015.48.1.78.CrossRefGoogle ScholarPubMed
Baird, CW, Chavez, M, Sleeper, LA, et al. Reintervention rates after bioprosthetic pulmonary valve replacement in patients younger than 30 years of age: a multicenter analysis. J Thorac Cardiovasc Surg 2021; 161: 345362 e2. DOI 10.1016/j.jtcvs.2020.06.157.CrossRefGoogle ScholarPubMed
McElhinney, DB, Sondergaard, L, Armstrong, AK, et al. Endocarditis after transcatheter pulmonary valve replacement. J Am Coll Cardiol 2018; 72: 27172728. DOI 10.1016/j.jacc.2018.09.039.CrossRefGoogle ScholarPubMed
McElhinney, DB. Prevention and management of endocarditis after transcatheter pulmonary valve replacement: current status and future prospects. Expert Rev Med Devices 2021; 18: 2330. DOI 10.1080/17434440.2021.1857728.CrossRefGoogle ScholarPubMed
Lupo, P, Cappato, R, Di Leo, G, et al. An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator. Eur Radiol 2018; 28: 24062416. DOI 10.1007/s00330-017-5098-z.CrossRefGoogle ScholarPubMed
Bireley, M, Kovach, JR, Morton, C, et al. Cardiac magnetic resonance imaging (MRI) in children is safe with most pacemaker systems, including those with epicardial leads. Pediatr Cardiol 2020; 41: 801808. DOI 10.1007/s00246-020-02316-z.CrossRefGoogle ScholarPubMed